Savaria Co. (TSE:SIS – Get Free Report) Director Les Teague sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of C$28.92, for a total transaction of C$144,600.00.
Savaria Stock Performance
Shares of SIS traded up C$0.04 during midday trading on Monday, reaching C$29.26. 47,967 shares of the stock were exchanged, compared to its average volume of 169,706. Savaria Co. has a twelve month low of C$19.20 and a twelve month high of C$30.62. The company has a quick ratio of 0.91, a current ratio of 1.71 and a debt-to-equity ratio of 31.42. The stock’s 50 day simple moving average is C$28.88 and its 200 day simple moving average is C$26.31. The company has a market cap of C$2.10 billion, a P/E ratio of 26.60, a PEG ratio of 42.72 and a beta of 1.06.
Savaria (TSE:SIS – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported C$0.31 earnings per share for the quarter. Savaria had a return on equity of 12.41% and a net margin of 8.50%.The firm had revenue of C$235.54 million during the quarter. On average, sell-side analysts expect that Savaria Co. will post 1.2048518 earnings per share for the current year.
Analysts Set New Price Targets
Get Our Latest Stock Report on SIS
About Savaria
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Further Reading
- Five stocks we like better than Savaria
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
